Lazarina, Elvie S.
HRN: 18 27 35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/27/2023
METRONIDAZOLE 500MG (TAB)
10/27/2023
10/31/2023
PO
500mg Tab
BID
Bacterial Vaginosis With Candidiasis
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes